STAT3 and non-small cell lung carcinoma: On the other hand, miR-197 inhibits Cyclin-dependent kinases regulatory subunit 1 (CKS1B) by decreasing STAT3 activation thus reducing PD-L1 expression on NSCLC cells [88].